The top characterized and screened genes including EGFR, MYC, VEGFA, PTEN which are involved in prostate cancer progression, cell proliferation and division, cell cycle signaling, metabolic and signaling pathway regulation, angiogenesis, focal adhesion etc. [40,41,42,43,44] Which makes them further as molecular candidates involved in treatment. The gene discussed is PTEN; the disease is prostate carcinoma.